NeuroSearch A/S

Denmark : NeuroSearch A/S announces end of stabilisation period in connection with the rights issue completed November 2009.
TendersInfo; 12/16/2009; 496 words; ...completion of a rights issue, NeuroSearch hereby announces that...2009. The right issue's joint global coordinators...division of Danske Bank A/S) and Handelsbanken Capital...have both informed NeuroSearch that no stabilisation...regards to the company's shares during the stabilisation...

Cytochroma Announces Appointment of Peter Moldt to Board of Directors.
Biotech Week; 12/9/2009; 549 words; ...subsequently took public. Before Curalogic A/S, he was Chief Operating Officer of 7TM Pharma A/S, a company which he cofounded in 2000. Prior to 2000, Dr. Moldt spent 11 years with NeuroSearch A/S, where he was responsible for all aspects...

S&P lowers target on NeuroSearch to DKK184.
Nordic Business Report; 11/24/2009; 587 words; ...REPORT-24 November 2009-S&P lowers target on NeuroSearch to DKK184(C)1994-2009...2009 - Standard & Poor's (S&P) Equity Research reduced...on Danish biopharma company NeuroSearch A/S (CPH: NEUR) to DKK184 from...

S&P Equity trims target on Danish NeuroSearch.
ADP News Nordic; 11/24/2009; 564 words; (ADPnews) - Nov 24, 2009 - Standard & Poor's (S&P) Equity Research reduced the share price target on Danish biopharma company NeuroSearch A/S (CPH:NEUR) to DKK 184 from DKK 194 and reiterated...

Danish NeuroSearch Q3 net loss shrinks to DKK19.3m.(Financial report)
Nordic Business Report; 11/16/2009; 575 words; ...2009 - Danish biopharma company NeuroSearch AS (CPH: NEUR) said today that...period a year ago. The company's revenue jumped to DKK46.5m from...share to DKK1.04 from DKK5.21. NeuroSearch's results for the first nine months...